Injective vs Metaplex — how do they compare? Injective trades at Rp92,485 (market cap Rp9,27T, Rp1,76T 24h volume), while Metaplex trades at Rp513.45 (market cap Rp262,55M, Rp221,35M 24h volume). The key difference: Injective is far larger — about 35307.6× Metaplex's market cap, and Metaplex's supply is capped (510M / 1B MPLX (51%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Metaplex for 14 Days on average.
| INJ | MPLX | |
|---|---|---|
Market Cap | Rp9,27T | Rp262,55M |
Volume (24h) | Rp1,76T | Rp221,35M |
Circulating Supply | 100M INJ | 510M / 1B MPLX (51%) |
Typical Hold Time | 36 Days | 14 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Metaplex (MPLX) is trading at Rp521.34 with a market cap of Rp263.93M, showing a bullish technical signal despite mixed moving averages. The token is currently testing resistance at Rp524 with strong support at Rp454. With 51% of the maximum 1M tokens in circulation and an average hold time of 14 days, the asset demonstrates moderate network participation. Recent technical indicators show oscillators leaning bullish while moving averages remain bearish, creating a mixed short-term picture.
Overall outlook is cautiously optimistic with the token testing key resistance levels. Key opportunities include potential breakout above Rp524 resistance, while major risks involve low liquidity given the modest market cap and typical cryptocurrency volatility. Investors should monitor whether the token can sustain momentum above current levels or faces rejection at resistance.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Metaplex plays a crucial role in one of the largest developer ecosystems in the blockchain world by providing the on-chain infrastructure needed to create nearly all tokens and NFTs on Solana and the Solana Virtual Machine (SVM). It is utilized by prominent launchpads, marketplaces, games, wallets, and various other applications, generating substantial revenue and transaction volume through its infrastructure.
Read more on MPLX →